CDR-Life AG
3Patents
3Active
3Granted
59Portfolio score
Filing activity: Mar 9, 2022 → Sep 13, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11912771B2 | MAGE-A4 peptide-MHC antigen binding proteins | Chemistry; Metallurgy | 1 | Active |
| US12344663B2 | Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases | Physics | 0 | Active |
| US12161673B2 | MAGE-A4 peptide dual T cell engagers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.